NCT00755378View on ClinicalTrials.gov

AZD8529 Single Ascending Dose Study

PHASE1CompletedINTERVENTIONAL

Enrollment

58

Participants

Timeline

Start Date

September 30, 2008

Study Completion Date

March 31, 2009

Conditions

Healthy Volunteer

Interventions

DRUG

AZD8529

Oral

DRUG

Placebo

Oral

Trial Locations (1)

Unknown

Research Site, Philadelphia

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY